ArticleBlood advances2020

Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma.

Richard T Maziarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.